Analysis of the 10q11 Cancer Risk Locus Implicates MSMB and NCOA4 in Human Prostate Tumorigenesis 英文参考文献.docVIP

下载本文档

5
0
约3.58万字
约 6页
2017-05-11 发布于上海
举报
版权申诉

Analysis of the 10q11 Cancer Risk Locus Implicates MSMB and NCOA4 in Human Prostate Tumorigenesis 英文参考文献.doc

1、本文档共6页，可阅读全部内容。
2、原创力文档（book118）网站文档一经付费（服务费），不意味着购买了该文档的版权，仅供个人/单位学习、研究之用，不得用于商业用途，未经授权，严禁复制、发行、汇编、翻译或者网络传播等，侵权必究。
3、本站所有内容均由合作方或网友上传，本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺！文档内容仅供研究参考，付费前请自行鉴别。如您付费，意味着您自己接受本站规则且自行承担风险，本站不退款、不进行额外附加服务；查看《如何避免下载的几个坑》。如果您已付费下载过本站文档，您可以点击这里二次下载。
4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等，请点击“版权申诉”（推荐），也可以打举报电话：400-050-0827(电话支持时间：9:00-18:30)。
5、该文档为VIP文档，如果想要下载，成为VIP会员后，下载免费。
6、成为VIP后，下载本文档将扣除1次下载权益。下载后，不支持退款、换文档。如有疑问请联系我们。
7、成为VIP后，您将拥有八大权益，权益包括：VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
8、VIP文档为合作方或网友上传，每下载1次，网站将根据用户上传文档的质量评分、类型等，对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档

Analysis of the 10q11 Cancer Risk Locus Implicates MSMB and NCOA4 in Human Prostate Tumorigenesis 英文参考文献

Analysisofthe10q11CancerRiskLocusImplicates MSMBandNCOA4inHumanProstateTumorigenesis MarkM.Pomerantz1,2.,YashaswiShrestha1,3,4.,RichardJ.Flavin5,MeredithM.Regan6,KathrynL. Penney7,LoreleiA.Mucci7,8,MeirJ.Stampfer7,8,9,DavidJ.Hunter7,8,9,StephenJ.Chanock10,EricJ. Schafer1,3,4,JenniferA.Chan11,JosepTabernero12,Jose′ Baselga12,AndreaL.Richardson13 ,Massimo Loda1,3,4,5,13,WilliamK.Oh14,PhilipW.Kantoff1,2,WilliamC.Hahn1,2,3,4,MatthewL.Freedman1,3,4 * 1DepartmentofMedicalOncology,Dana-FarberCancerInstitute,Boston,Massachusetts,UnitedStatesofAmerica,2DepartmentofMedicine,BrighamandWomen’s Hospital andHarvardMedicalSchool, Boston, Massachusetts,United States ofAmerica, 3Centerfor Cancer Genome Discovery, Dana-Farber Cancer Institute, Boston, Massachusetts,UnitedStatesofAmerica,4BroadInstituteofHarvardandMassachusettsInstituteofTechnology,Cambridge,Massachusetts,UnitedStatesofAmerica, 5Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Brigham and Women’s Hospital, Boston, Massachusetts, United States of America, 6Department ofBiostatisticsandComputationalBiology,Dana-FarberCancerInstituteandHarvardMedicalSchool,Boston, Massachusetts,UnitedStatesofAmerica, 7Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, United States of America, 8Channing Laboratory, Department of Medicine, BrighamandWomen’sHospitalandHarvardMedicalSchool,Boston,Massachusetts,UnitedStatesofAmerica,9DepartmentofNutrition,HarvardSchoolofPublicHealth, Boston, Massachusetts, United States ofAmerica, 10Division ofCancer Epidemiologyand Genetics, National Cancer Institute,National Institutes of Health, Bethesda, Maryland,UnitedStatesofAmerica,11DepartmentofPathologyandLaboratoryMedicine,UniversityofCalgary,Calgary,Alberta,Canada,12Valld’HebronInstituteof Oncology, Vall d’Hebron University Hospital, Barcelona, Spain, 13Department of Pathology, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts,UnitedStatesofAmerica,14T